Patient safety is paramount in the development of cancer therapies. Regulatory affairs professionals ensure that all clinical trials adhere to ethical standards and that any potential risks are identified and mitigated. They oversee the accurate reporting of adverse events and ensure that the benefits of a new therapy justify its risks. Their work is crucial in safeguarding patients and maintaining public trust in new cancer treatments.
